- Filed
- Mar 3, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 3, 2026 | 25.44M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 23.26M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 18.57M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 12.41M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 11.16M sh |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2025 | −$2.4M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$1.11M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $809.1K |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $840.25K |
| Short Term Debt restated | Q3 2025 · Sep 30, 2024 | $896.25K |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $65.18K |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $64.74K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $192.07K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $248.38K |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2025 | $12.06M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.23M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $1.64M |
| Current Liabilities restated | Q3 2025 · Sep 30, 2025 | $6.54M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $6.56M |
| Current Liabilities restated | Q3 2025 · Sep 30, 2024 | $6.25M |
| Total Liabilities restated | Q3 2025 · Sep 30, 2025 | $6.72M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $6.82M |
| Total Liabilities restated | Q3 2025 · Sep 30, 2024 | $6.44M |
| Current Assets restated | Q3 2025 · Sep 30, 2025 | $3.31M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.18M |
| Current Assets restated | Q3 2025 · Sep 30, 2024 | $2.17M |
| Total Assets restated | Q3 2025 · Sep 30, 2025 | $21.21M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $7.54M |
| Total Assets restated | Q3 2025 · Sep 30, 2024 | $7.78M |
| Eps Diluted restated | Q3 2025 · Sep 30, 2025 | −$0.09 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2025 | −$0.28 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.03 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.37 |
| Eps Basic restated | Q3 2025 · Sep 30, 2025 | −$0.09 |
| Eps Basic restated | Q3 2025 · Sep 30, 2025 | −$0.28 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.03 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.37 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $798.25K |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.1M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $557.6K |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $1.95M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $29.89K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $92.03K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $37.83K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $147.29K |
| Net Income restated | Q3 2025 · Sep 30, 2025 | −$2.04M |
| Net Income restated | Q3 2025 · Sep 30, 2025 | −$5.14M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$394.77K |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$4.17M |
| Operating Income restated | Q3 2025 · Sep 30, 2025 | −$1.96M |
| Operating Income restated | Q3 2025 · Sep 30, 2025 | −$4.95M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$302.32K |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$4M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $388.98K |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $506.86K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $296 |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $763 |
| Revenue | Q3 2025 · Sep 30, 2024 | $389.28K |
| Revenue | Q3 2025 · Sep 30, 2024 | $507.62K |